Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization
- PMID: 14508521
- DOI: 10.1038/sj.onc.1206737
Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization
Abstract
Mammary epithelial cells are embedded in a unique extracellular environment to which adipocytes and other stromal cells contribute. Mammary epithelial cells are critically dependent on this milieu for survival. However, it remains unknown which adipocyte-secreted factors are required for the survival of the mammary epithelia and what role these adipokines play in the process of ductal carcinoma tumorigenesis. Here, we take a systematic molecular approach to investigate the multiple ways adipocytes and adipokines can uniquely influence the characteristics and phenotypic behavior of malignant breast ductal epithelial cells. Microarray analysis and luciferase reporter assays indicate that adipokines specifically induce several transcriptional programs involved in promoting tumorigenesis, including increased cell proliferation (IGF2, FOS, JUN, cyclin D1), invasive potential (MMP1, ATF3), survival (A20, NFkappaB), and angiogenesis. One of the key changes in the transformed ductal epithelial cells associated with the cell cycle involves the induction of NFkappaB (five-fold) and cyclin D1 (three-fold). We show that by regulating the transcription of these molecules, the synergistic activity of adipocyte-derived factors can potentiate MCF-7 cell proliferation. Furthermore, compared to other stromal cell-secreted factors, the full complement of adipokines shows an unparalleled ability to promote increased cell motility, migration, and the capacity for angiogenesis. Adipocyte-secreted factors can affect tumorigenesis by increasing the stabilization of pro-oncogenic factors such as beta-catenin and CDK6 as a result of a reduction in the gene expression of their inhibitors (i.e. p18). An in vivo coinjection system using 3T3-L1 adipocytes and SUM159PT cells effectively recapitulates the host-tumor interactions in primary tumors. Type VI collagen, a soluble extracellular matrix protein abundantly expressed in adipocytes, is further upregulated in adipocytes during tumorigenesis. It promotes GSK3beta phosphorylation, beta-catenin stabilization, and increased beta-catenin activity in breast cancer cells and may critically contribute towards tumorigenesis when not counterbalanced by other factors.
Similar articles
-
Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment.J Clin Invest. 2005 May;115(5):1163-76. doi: 10.1172/JCI23424. Epub 2005 Apr 14. J Clin Invest. 2005. PMID: 15841211 Free PMC article.
-
Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.Oncogene. 2001 Nov 15;20(52):7645-57. doi: 10.1038/sj.onc.1204980. Oncogene. 2001. PMID: 11753642
-
Kinase-inactive glycogen synthase kinase 3beta promotes Wnt signaling and mammary tumorigenesis.Cancer Res. 2005 Jul 1;65(13):5792-801. doi: 10.1158/0008-5472.CAN-05-1021. Cancer Res. 2005. PMID: 15994955
-
New steps in the Wnt/beta-catenin signal transduction pathway.Recent Prog Horm Res. 2000;55:225-36. Recent Prog Horm Res. 2000. PMID: 11036939 Review.
-
Beta-catenin and Tcfs in mammary development and cancer.J Mammary Gland Biol Neoplasia. 2003 Apr;8(2):145-58. doi: 10.1023/a:1025944723047. J Mammary Gland Biol Neoplasia. 2003. PMID: 14635791 Review.
Cited by
-
Towards Understanding the Development of Breast Cancer: The Role of RhoJ in the Obesity Microenvironment.Cells. 2024 Jan 17;13(2):174. doi: 10.3390/cells13020174. Cells. 2024. PMID: 38247865 Free PMC article.
-
Inhibition of PPARγ by BZ26, a GW9662 derivate, attenuated obesity-related breast cancer progression by inhibiting the reprogramming of mature adipocytes into to cancer associate adipocyte-like cells.Front Pharmacol. 2023 Aug 15;14:1205030. doi: 10.3389/fphar.2023.1205030. eCollection 2023. Front Pharmacol. 2023. PMID: 37649895 Free PMC article.
-
Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma.Cell Mol Life Sci. 2023 Jul 28;80(8):233. doi: 10.1007/s00018-023-04887-5. Cell Mol Life Sci. 2023. PMID: 37505240 Free PMC article.
-
Nuclear magnetic resonance-determined lipoprotein profile and risk of breast cancer: a Mendelian randomization study.Breast Cancer Res Treat. 2023 Jul;200(1):115-126. doi: 10.1007/s10549-023-06930-2. Epub 2023 May 10. Breast Cancer Res Treat. 2023. PMID: 37162625
-
NCoA3 upregulation in breast cancer‑associated adipocytes elicits an inflammatory profile.Oncol Rep. 2023 May;49(5):105. doi: 10.3892/or.2023.8542. Epub 2023 Apr 7. Oncol Rep. 2023. PMID: 37026525 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
